Applied Therapeutics, Inc. — Director's Dealing 2021

May 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2021-05-10

Reporting Person: Mahadevan Chids (Chief Accounting Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-10	Common Stock	A	8544	$0.00	Acquired	8544	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-10	Stock Option (Right to Buy)	$17.05	A	13412	Acquired	2031-05-10	Common Stock (13412)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	25	Direct

Footnotes

F1: Consists of Restricted Stock Units, representing a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the Restricted Stock Units were vested upon grant and one-fourth (1/4th) of the Restricted Stock Unites shall vest thereafter on each of May 10, 2022, May 10, 2023 and May 10, 2024,subject to the Reporting Person continuing to provide services through each such date.

F2: One-fourth (1/4th) of the shares subject to the Option were vested upon grant and the remainder of the shares subject to the Option shall vest thereafter in equal monthly installments over the three-year period following the date of grant, subject to the Reporting Person continuing to provide services through each such date.